Wockhardt Ltd
WOCKPHARMA
Company Profile
Business description
Wockhardt Ltd is a world-wide pharmaceutical and biotech company with presence in UK, Switzerland, Ireland, Russia and many other countries. It has manufacturing and research facilities in India & UK and a manufacturing facility in Ireland and Dubai. The company's only reportable business segment is Pharmaceutical business. It has presence in India, USA, Europe, Rest of the world. The company generates majority of revenue from Europe.
Contact
Bandra-Kurla Complex
Wockhardt Towers
Bandra East
MumbaiMH400051
INDT: +91 2226534444
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
4,084
Stocks News & Analysis
stocks
Nvidia: Hugging Face acquisition both a wise offensive and defensive move
We think this improves Nvidia’s position within the open-source community.
stocks
Anthropic’s IPO will be huge—and risky. Here are the challenges investors should watch
Part two of a Q&A with PitchBook senior analyst Harrison Rolfes about Anthropic, the AI giant’s challenges, and how much it’s worth.
stocks
Chart of the Week: China demand for copper falls amidst record rally
Elevated copper prices raise valuation questions.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,188.40 | 62.20 | -0.67% |
| CAC 40 | 8,286.40 | 5.77 | 0.07% |
| DAX 40 | 26,003.32 | 163.99 | 0.63% |
| Dow JONES (US) | 53,686.11 | 624.16 | 1.18% |
| FTSE 100 | 10,831.52 | 75.07 | 0.70% |
| HKSE | 25,737.60 | 524.29 | 2.08% |
| NASDAQ | 26,584.06 | 366.23 | 1.40% |
| Nikkei 225 | 64,963.16 | 748.68 | 1.17% |
| NZX 50 Index | 13,934.40 | 88.22 | 0.64% |
| S&P 500 | 7,747.71 | 81.11 | 1.06% |
| S&P/ASX 200 | 8,999.80 | 70.40 | -0.78% |
| SSE Composite Index | 3,955.85 | 13.76 | 0.35% |